Cargando…

Cardiovascular Safety During and After Use of Phentermine and Topiramate

CONTEXT: Increases in heart rate were seen during the clinical program for fixed-dose combination phentermine (PHEN) and topiramate (TPM), an oral medication indicated for weight management; however, the effect on cardiovascular (CV) outcomes is uncertain. OBJECTIVE: The aim of the present study was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ritchey, Mary E, Harding, Abenah, Hunter, Shannon, Peterson, Craig, Sager, Philip T, Kowey, Peter R, Nguyen, Lan, Thomas, Steven, Cainzos-Achirica, Miguel, Rothman, Kenneth J, Andrews, Elizabeth B, Anthony, Mary S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2018
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318778/ https://www.ncbi.nlm.nih.gov/pubmed/30247575 http://dx.doi.org/10.1210/jc.2018-01010

Ejemplares similares

Phentermine and topiramate for the management of obesity: a review
por: Cosentino, Gina, et al.
Publicado: (2011)

Phentermine-topiramate: First combination drug for obesity
por: Singh, Jagjit, et al.
Publicado: (2015)

A Narrative Review: Phentermine and Topiramate for the Treatment of Pediatric Obesity
por: Kim, Anthony, et al.
Publicado: (2023)

Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity
por: Jordan, Jens, et al.
Publicado: (2014)

Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity
por: Shin, Jin Hee, et al.
Publicado: (2013)

Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
por: Allison, David B., et al.
Publicado: (2012)

Management of obesity and cardiometabolic risk – role of phentermine/extended release topiramate
por: Sweeting, Arianne N, et al.
Publicado: (2014)

Combination of venlafaxine and phentermine/topiramate induced psychosis: A case report
por: Homola, Jaclyn, et al.
Publicado: (2018)

Formulary Management of 2 New Agents: Lorcaserin and Phentermine/Topiramate for Weight Loss
por: Kelly, Elizabeth M., et al.
Publicado: (2013)

Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release
por: Garvey, W. Timothy, et al.
Publicado: (2014)

Phentermine–topiramate extended release for the dual treatment of obesity and sleep-related eating disorder: a case report
por: Grunvald, Eduardo, et al.
Publicado: (2022)

RE: Pulmonary Hypertension Associated with Use of Phentermine?
por: Hendricks, Ed J., et al.
Publicado: (2011)

4-Year Cost Trajectories in Real-World Patients Matched to the Metabolic Profiles of Trial Subjects Before/After Treatment with Phentermine-Topiramate
por: Li, James, et al.
Publicado: (2015)

Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management
por: Garvey, William Timothy
Publicado: (2013)

Polypill for Population-Level Primary Cardiovascular Prevention in Underserved Populations—A Social Epidemiology Counterargument
por: Cainzos-Achirica, Miguel, et al.
Publicado: (2020)

Cardiovascular risk perception in women: true unawareness or risk miscalculation?
por: Cainzos-Achirica, Miguel, et al.
Publicado: (2015)

The Evolving Landscape of Cardiovascular Disease Prevention
por: Cainzos-Achirica, Miguel, et al.
Publicado: (2021)

Case report of PLXNA4 variant associated with hyper-response to phentermine/topiramate pharmacotherapy: Potential genetic basis for superior weight loss response?
por: Paszkowiak, Maria, et al.
Publicado: (2023)

Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study
por: Gilsenan, Alicia, et al.
Publicado: (2019)

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study(1)(2)(3)
por: Garvey, W Timothy, et al.
Publicado: (2012)

Phentermine, Sibutramine and Affective Disorders
por: An, Hoyoung, et al.
Publicado: (2013)

Obesity pillars roundtable: Phentermine – Past, present, and future
por: Bays, Harold Edward, et al.
Publicado: (2022)

Pulmonary Hypertension Associated with Use of Phentermine
por: Bang, Woo-Dae, et al.
Publicado: (2010)

Cardiovascular Disease Prevention During the COVID-19 Pandemic: Lessons Learned and Future Opportunities
por: Duffy, Eamon, et al.
Publicado: (2021)

The Use of Phentermine for Obesity in Psychiatric Patients With Antipsychotics
por: Kim, Eunju, et al.
Publicado: (2023)

Socioeconomic status, cardiovascular risk profile, and premature coronary heart disease
por: Khan, Safi U., et al.
Publicado: (2022)

Cardiometabolic Disease Staging Predicts Effectiveness of Weight-Loss Therapy to Prevent Type 2 Diabetes: Pooled Results From Phase III Clinical Trials Assessing Phentermine/Topiramate Extended Release
por: Guo, Fangjian, et al.
Publicado: (2017)

Takotsubo Cardiomyopathy Due to Combined Use of Phentermine and Lisdexamfetamine
por: Burleigh, Tara, et al.
Publicado: (2020)

A Rare Case of Phentermine-Induced Nonischemic Cardiomyopathy
por: Damani, Devanshi, et al.
Publicado: (2022)

Leveling the playing field: The utility of coronary artery calcium scoring in cardiovascular risk stratification in South Asians
por: Agarwala, Anandita, et al.
Publicado: (2022)

Effects of Orlistat/Phentermine versus Phentermine on Vascular Endothelial Cell Function in Obese and Overweight Adults: A Randomized, Double-Blinded, Placebo-Controlled Trial
por: Kwon, Yu-Jin, et al.
Publicado: (2021)

Postmarketing Surveillance Study of the Efficacy and Safety of Phentermine in Patients with Obesity
por: Kim, Hyun Ok, et al.
Publicado: (2013)

Abstract: Phentermine: A Systematic Review for Plastic & Reconstructive Surgeons
por: Lim, Soobin, et al.
Publicado: (2018)

MON-095 Phentermine Induces Weight Loss in Prader-Willi Syndrome
por: Mottalib, Adham, et al.
Publicado: (2019)

Phentermine Use During First and Second Trimesters Associated with Fetal Stroke
por: D'Adesky, Nathan, et al.
Publicado: (2019)

Phentermine-Associated Atrial Fibrillation: A Case Report and Literature Review
por: Manasrah, Nouraldeen, et al.
Publicado: (2022)

Effect of Phentermine on Hepatic Steatosis in Bariatric Surgery: A Pilot Study
por: Pérez-Cruz, Elizabeth, et al.
Publicado: (2022)

Positive Regadenoson Stress Test in a Patient on Phentermine With Normal Coronaries
por: Sendil, Selin, et al.
Publicado: (2022)

Lorcaserin and phentermine exert anti-obesity effects with modulation of the gut microbiota
por: Song, Eun-Ji, et al.
Publicado: (2023)

Measures of Financial Hardship From Health Care Expenses Among Families With a Member With Atherosclerotic Cardiovascular Disease in the US
por: Wang, Stephen Y., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bb0di0aach6nr7gs8n229dlmvg